Literature DB >> 8500308

A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial.

S D Mark1, J M Robins.   

Abstract

The standard approach to analyzing randomized trials ignores information on postrandomization compliance. Application of these methods results in estimates that may lack the desired causal interpretation. We employ a new method of estimation and analyze data from the Multiple Risk Factor Intervention Trial (MRFIT) to estimate the causal effect of quitting cigarette smoking. Our procedure utilizes a method proposed by Robins and Tsiatis and allows us to take advantage of postrandomization smoking history without requiring untenable assumptions about the comparability of compliers and noncompliers. We contrast the performance of our method and the standard intent-to-treat analysis in the MRFIT data and in simulated data in which compliance rates are varied.

Mesh:

Year:  1993        PMID: 8500308     DOI: 10.1016/0197-2456(93)90012-3

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  19 in total

1.  Causal inference from longitudinal studies with baseline randomization.

Authors:  Sengwee Toh; Miguel A Hernán
Journal:  Int J Biostat       Date:  2008-10-19       Impact factor: 0.968

2.  Extended instrumental variables estimation for overall effects.

Authors:  Marshall M Joffe; Dylan Small; Thomas Ten Have; Steve Brunelli; Harold I Feldman
Journal:  Int J Biostat       Date:  2008-04-07       Impact factor: 0.968

3.  Empirical efficiency maximization: improved locally efficient covariate adjustment in randomized experiments and survival analysis.

Authors:  Daniel B Rubin; Mark J van der Laan
Journal:  Int J Biostat       Date:  2008       Impact factor: 0.968

Review 4.  Methodological challenges in causal research on racial and ethnic patterns of cognitive trajectories: measurement, selection, and bias.

Authors:  M Maria Glymour; Jennifer Weuve; Jarvis T Chen
Journal:  Neuropsychol Rev       Date:  2008-09-26       Impact factor: 7.444

5.  Adjusting for the Confounding Effects of Treatment Switching-The BREAK-3 Trial: Dabrafenib Versus Dacarbazine.

Authors:  Nicholas R Latimer; Keith R Abrams; Mayur M Amonkar; Ceilidh Stapelkamp; R Suzanne Swann
Journal:  Oncologist       Date:  2015-06-03

Review 6.  Observational studies versus randomized controlled trials: avenues to causal inference in nephrology.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Adv Chronic Kidney Dis       Date:  2012-01       Impact factor: 3.620

7.  Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization.

Authors:  Sengwee Toh; Sonia Hernández-Díaz; Roger Logan; James M Robins; Miguel A Hernán
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

8.  Beyond the intention-to-treat in comparative effectiveness research.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz
Journal:  Clin Trials       Date:  2011-09-23       Impact factor: 2.486

9.  Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials.

Authors:  Eleanor J Murray; Miguel A Hernán
Journal:  Clin Trials       Date:  2016-03-07       Impact factor: 2.486

10.  Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death.

Authors:  Stephen R Cole; Lisa P Jacobson; Phyllis C Tien; Lawrence Kingsley; Joan S Chmiel; Kathryn Anastos
Journal:  Am J Epidemiol       Date:  2009-11-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.